Study of the role of retinoblastoma protein in terminal differentiation of murine erythroleukemia cells.

AUTOR(ES)

Zhuo, S

RESUMO

Hexamethylenebisacetamide-induced terminal differentiation of Friend virus-transformed murine erythroleukemia (MEL) cells can be inhibited by okadaic acid, an inhibitor of type 1 and type 2A protein phosphatases. The inhibition is shown to be correlated with prevention of dephosphorylation of retinoblastoma protein (pRB) in cells and bypass of G1 prolongation in the cell cycle. These results suggest that pRB-mediated G1 prolongation is necessary for MEL cells to commit to terminal differentiation. However, further experiments demonstrate that the simple cell cycle exit is not sufficient for commitment to terminal differentiation. Induction of dephosphorylation of pRB and subsequent G1 prolongation by forskolin does not lead MEL cells to differentiate. Additional pRB has been expressed in MEL cells by transfection with a neo-resistant plasmid containing RB cDNA under the control of a cytomegalovirus promoter. Exogenously expressed pRB is hyperphosphorylated in logarithmically growing MEL cells without any noticeable change in growth rate between the transfected cell line and the parental cell line. This result suggests that pRB in MEL cells is regulated by protein kinases and protein phosphatases and not by transcription.

Documentos Relacionados

• Introduction of the beta isozyme of protein kinase C accelerates induced differentiation of murine erythroleukemia cells.
• A new group of potent inducers of differentiation in murine erythroleukemia cells.
• Only the DNA binding and transactivation domains of c-Myb are required to block terminal differentiation of murine erythroleukemia cells.
• Role of the PU.1 transcription factor in controlling differentiation of Friend erythroleukemia cells.
• Retinoblastoma Protein Plays Multiple Essential Roles in the Terminal Differentiation of Sertoli Cells